Isfahan University of Medical Sciences

NCT06595355

Phase 2/3, Status unknown, 2021, 52 people, 19 Sept 2024, clinicaltrials.gov

NCT05973253

Phase 2/3, Completed, 2023, 74 people, 2 Aug 2023, clinicaltrials.gov

NCT05324995

Phase 2, Completed, 2021, 146 people, 13 Apr 2022, clinicaltrials.gov

NCT05268419

Collaborator, Phase 3, Completed, 2021, 150 people, 7 Mar 2022, clinicaltrials.gov

NCT04414800

Phase 3, Completed, 2017, 125 people, 4 Jun 2020, clinicaltrials.gov

NCT04143321

Phase 4, Completed, 2018, 75 people, 29 Oct 2019, clinicaltrials.gov

NCT03894683

Phase 2, Status unknown, 2018, 90 people, 28 Mar 2019, clinicaltrials.gov

NCT03747081

Phase 1/2, Status unknown, 2018, 50 people, 20 Nov 2018, clinicaltrials.gov

NCT03531970

Phase 2/3, Completed, 2016, 100 people, 22 May 2018, clinicaltrials.gov

NCT03499886

Phase 2/3, Status unknown, 2017, 198 people, 17 Apr 2018, clinicaltrials.gov

NCT02939079

Phase 2/3, Completed, 2015, 50 people, 19 Oct 2016, clinicaltrials.gov

NCT02114346

Phase 2/3, Completed, 2013, 250 people, 15 Apr 2014, clinicaltrials.gov

NCT02113540

Phase 3, Status unknown, 2012, 14 Apr 2014, clinicaltrials.gov

NCT02090907

Phase 2/3, Completed, 2013, 50 people, 18 Mar 2014, clinicaltrials.gov

NCT02088502

Phase 2/3, Status unknown, 2013, 96 people, 17 Mar 2014, clinicaltrials.gov

NCT01837446

Phase 2/3, Completed, 2011, 30 people, 23 Apr 2013, clinicaltrials.gov

NCT01807429

Phase 2/3, Completed, 2012, 236 people, 8 Mar 2013, clinicaltrials.gov

NCT01763424

Phase 2/3, Completed, 2011, 66 people, 8 Jan 2013, clinicaltrials.gov

NCT01718678

Phase 2, Completed, 2012, 44 people, 31 Oct 2012, clinicaltrials.gov

NCT01465893

Phase 2, Status unknown, 2011, 60 people, 7 Nov 2011, clinicaltrials.gov

Dietary approaches to stop hypertension (DASH) in relation to hyper-triglyceridemic-waist (HTGW) phenotype in Iranian adults

15 Sept 2026, api.crossref.org